伟德国际网址1946

伟德国际网址1946

Company Profile

LifeTech Scientific Corporation (Stock Code: 1302.HK) is the leading supplier of minimally invasive interventional medical devices to treat cardiovascular diseases. The company specializes in R&D, manufacture and sales, and its high-quality, innovative, proprietary products are extensively marketed in more than 100 countries by over 300 distributors. At present, the company is the world second largest supplier (and the largest among BRIC countries) of occluders to treat congenital heart diseases and the second largest supplier of aortic repair device in Asia Pacific.


Lifetech Scientific (Shenzhen) Co., Ltd., the subsidiary of Lifetech, was established in 1999, and other subsidiaries and sales offices were subsequently setup in Hong Kong, India, Netherland, France, Russia, America, Greece, Beijing, Shanghai, Guangzhou and etc. In November 2011, the company was successfully listed on the Hong Kong Stock Exchange with the market cap nearly 10 billion HKD.


As a result of its pursuit for quality and innovation, the quality system of LifeTech Scientific Corporation was accredited by the DEKRA in EU (ISO13485:2003), and passed inspection of Good Manufacturing Practice for Chinese Medical Devices. The company was rated as a National High-Tech Enterprise in 2008, and has obtained scientific research qualifications such as National Post-Doctoral Research Center, National and Local Joint Engineering Laboratory, etc. The company has also undertaken more than 50 government research projects, including the National Key Technology Research and Development Program of China under the “Tenth Five-Year Plan, the National Basic Research Program (973 Program) and the National High Technology Research and Development Program of China (863 Program). At the end of 2017, 6 products of the company have been approved as innovative medical devices by China Food and Drug Administration (CFDA).


Going forward, LifeTech Scientific Corporation is committed to enriching its product portfolio, improving product quality and enhancing medical services, to provide safe and innovative medical devices for doctors and patients globally and consistently contribute to the development of the industry.

Culture

[Vision]

To become a global leader in providing innovative medical devices for the treatment of cardiovascular diseases.


[Mission]

To provide doctors and patients around the world with safe and innovative cardiovascular medical devices.


[Cultural]

Vision
Through our advanced technology and innovative spirit, we aim to become the worldwide leader in minimally invasive medical devices for cardiovascular diseases and disorders.


Innovation
Our innovation is inspired by our users: doctors. Because of this we are seen as the preferred partner in developing and providing life-saving medical technology.


Passion
Our passion is to strive for perfection and serve our customers and patient’s needs through our Lifetech brand products and services. Our product quality, sales, marketing and distribution expertise, combined with our government partnerships has enabled us to win our customer’s support as the leading provider of medical devices.


Teamwork
We believe that together we can achieve anything. Therefore our company is built around teamwork, collaboration and communication. We recognize every employee as a vital member to our team and strive to build a synergistic culture to achieve the impossible.

Board of Directors

  • XIE Yuehui

    Executive Directors、Chairman and CEO

    XIE Yuehui is our chairman,Chief Executive Officer and our executive Director,Mr.XIE has about 27 years of experience in business management in the PRC,including over 15 years in the medical device industry. Investment Manager at a subsidiary of China Southern Securities, General Manager at an investment branch of Bank of China,Manager at the domestic trade department of Shenzhen Huihua Group, General Manager at Shenzhen Huishibang Technology Company Limited and than promoted to the chairman.He graduated from Kunming Institute of Technology in 1991 with a bachelor’s degree, and also obtained a master’s degree in Business Administration from Tsinghua University in 2006.
  • LIU Jianxiong

    Executive Directors、Vice Prerident and CFO

    LIU Jianxiong is our Vice President, Chief Financial Officer (“CFO”) and Company Secretary,has nearly 25 years experience in the accounting field. He served as at Kwan Wong Tan & Fong (currently Deloitte Touche Tohmatsu), he was the accounting services manager of Yantian International Container Terminal Company Limited, financial controller of Shenzhen Schlumberger Electronic System Solution Co., Ltd.. China financial manager of the China Light & Power Group renewable energy division,Great China corporate controller of AnyDATA Group. He graduated from Sun Yat-sen University in 1990 and obtained a master’s degree in business administration from University of Glamorgan in the United Kingdom in 2004. He has been a member of the Association of Chartered Certified Accountants since 1997 and a registered tax Agent since 1999.
  • JIANG Feng

    Non-executive Directors

    Jiang Feng is our non-executive Director. He is currently standing vice president of China Association for Medical Devices Industry, chairman of China Strategic Alliance of Medical Innovation, deputy of Biomedical Engineering Education Steering Committee of the Ministry of Education, executive director of Instrument and Control Society and chairman of its medical devices branch, executive director of Chinese Society of Biomedical Engineering, Chinese Society for Biomaterials and China Association for Disaster & Emergency Rescue Medicine researcher of Zhejiang University and director of Biomedical Technology Assessment Centre of Zhejiang University and president of the magazine China Medical Device Information.He graduated from the Fourth Military Medical University with a degree of bachelor of medicine in 1985 and received his doctoral degree of clinical surgery in 1995 from the Fourth Military Medical University.He obtained and EMBA degree from Tsinghua University in 2007.
  • LIANG Hsien Tse Joseph

    Independent non-executive Directors

    Liang Hsien Tse Joseph is our independent non-executive Director and has extensive experience in finance and accounting. He served as the Managing Director of the financial planning and development department at United International College in Zhuhai, PRC, a Director at Shenzhen Alclear Consulting Limited, and also served various roles at Skyworth Digital Holdings Limited, including the group’s Financial Comptroller and company Secretary in charge of finance and MIS functions of the Group. He graduated from Hong Kong Open University with a bachelor’s degree in language and translation in 2007, obtained a master’s degree in professional accounting from University of Texas in 1981 and a diploma in business management from Hong Kong Baptist College in 1977. He is a member of the Texas Society of Certified Public Accountants, Hong Kong Institute of Certified Public Accountants since 1982 and Association of Certified Chartered Accountants (ACCA) since 1982.
  • WANG Wansong

    Independent non-executive Directors

    WANG Wansong was appointed as an independent non-executive Director on 29 January 2016. Mr. WANG has an extensive experience in plans establishment, and policies formulation and implementation for the High-Tech industrial development and construction in Shenzhen, as well as in technological innovation,achievements transformation, and projects implementation and co-ordination for high-tech bio-pharmaceutical industry and medical device industry. He is currently working as a senior researcher at the State High-Tech Industrial Innovation Center in Shenzhen. Mr. WANG used to work at National Development and Reform Commission, Shenzhen City,Shenzhen Xinhuayu Marine Environmental Technology Engineering Co., Ltd.*, and in Jiujiang Environmental Protection Bureau, Jiangxi province. Mr. WANG holds a bachelor degree in Biology from the Peking University.
  • ZHOU Luming

    Independent non-executive Directors

    Zhou Luming is our independent non-executive Director.He is currently a dean of the Southern Institute of Science and Technology of Space. He was a teacher in South-Central University for Nationalities from 1984 to 1992.From 1992 to 2001, he served with Shenzhen Technology Bureau as head of the compliance division, director of general office and head of the planning division. He acted as deputy dean of Research Institute of Tsinghua University in Shenzhen from 2001 to 2004 and the deputy director of Shenzhen Technology Bureau from 2004 to 2008 and served as Chairman of Shenzhen Science and Technology Association from 2008 to 2014. He graduated in 1984 from the Department of Physics, Central China Normal University, and received his EMBA degree after graduating from Tsinghua University in 2005.

Development History

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2006
  • 2003
  • 2001
  • 1999
  • 2018

    The FIM for the IBS™ sirolimus-eluting iron absorbable coronary stent system was approved

  • 2018

    Strategic cooperation with All Bridge Group

  • 2017

    The [YY/T 1553-2017 industrial standard for Cardiovascular implants and Cardiac occluders] developed predominantly by LifeTech was approved by CFDA and brought into practice

  • 2017

    Iliac Bifurcation Stent Graft System- The 6th product entered CFDA Green Channel

  • 2017

    伟德国际网址™ LAAO & HeartTone™ pacemark was approved by CFDA

  • 2016

    伟德国际网址™ LAAO was approved by CE

  • 2016

    Pacemaker production line was established

  • 2015

    Pacemaker workshop was established in Shenzhen

  • 2015

    The advanced animal laboratory was established in Shenzhen

  • 2015

    Constituent stock of Hang Seng index

  • 2014

    Second prize of National Technological Invention Award

  • 2014

    伟德国际网址™ and IBS™ entered CFDA green channel

  • 2014

    CeraFle™ became the first Chinese brand entered the mainstream western market

  • 2013

    National and local joint engineering laboratory of Interventional Medical Biotechnology

  • 2012

    Strategic cooperation with Medtronic

  • 2011

    Listed on the Hong Kong Stock Exchange(stock code:1302.HK)

  • 2010

    Approved postdoctoral research stations

  • 2010

    SeQur™ Snare -First product received FDA clearance

  • 2009

    Cer™ ASD/VSD/PDA Occluders- First product series obtained CE mark approval

  • 2008

    Certified as National high-tech enterprise

  • 2006

    Invested by US.VC fund

  • 2003

    Certified as Shenzhen high-tech enterprise

  • 2001

    伟德国际网址™ PDA Occluder –First product was approved by CFDA

  • 1999

    Lifetech Scientific (Shenzhen)Co.Ltd., establishment

Sales and Marketing

We have established a well-developed sales, marketing and distribution network. We have over 180 distributors worldwide; including more than 30 distributors covering Europe, North America, South America, Asia and Africa.


We primarily focus on fast growing, emerging and/or underserved markets and will continue to move into more mature markets proactively in the future.

Over 50overseas distributors

Over 130domestic distributors


We have a professional marketing team to work on internal sales training and dealer management, formulating the best industry standards, assessing market opportunity, and maintaining client relations and direct interaction with physicians and hospitals.


Our brand value is built on the basis of professional education, evidence-based medicine and knowledge sharing. Therefore, we created LKEP program (Lifetech Knowledge Exchange Program) in 2011. This platform is created to facilitate the knowledge exchange between physicians from different regions. So far, we have set up a great number of exchange centres; Experts from Europe, Latin American and Asia have participated in LKEP program and have done cases to share their techniques, experiences and feedbacks.


We are devoted to promote our product through professional training and patient education. We have set up international training centers for interventional therapy of congenital heart disease in Brazil, Italy, India, Greece, as well as Beijing, Shanghai, Guangzhou, Harbin, Tianjin, and Guangxi.

Manufacturing and Quality Control


Quality Policy

We are committed to providing doctors and patients around the world with safe and innovative medical devices for the treatment of cardiovascular diseases.

We pledge that we will meet all regulatory requirements and maintain an effective quality management system.


The manufacturing process system adheres to the quality awareness with high standard and principles that strictly abide by and effectively implement it. Lifetech has employees with high quality and strict requirement from the general workers, technical personnel to management team.


All staff understand that Lifetech focuses on the implemental medical devices with high glory and adventures, and that to assure the quality is essential to the company’s reputation and patients’health. The sustained QCC and “Golden Idea” cultivate every employee’s awareness of the quality improvement involved by every one and costs controlling.


The gradually improved training mechanism crossing different products and with multi-skills and storing managing echelon staff are the strong strength and insurance for sustainable development.


The perfect process and systemized management mode, advanced equipment and flexible and fast and production are the strong cornerstone to satisfying the costumers’ individual needs.